Shockwave Medical Inc
F:36M
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Shockwave Medical Inc
F:36M
|
11.3B EUR |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.7B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
184.6B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
134.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
128.9B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.1B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.8B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Shockwave Medical Inc
Glance View
Shockwave Medical Inc. has established itself as a significant player in the healthcare sector thanks to its innovative approach to tackling calcified cardiovascular disease. Founded with the vision of addressing the inefficiencies and limitations of traditional treatment methods, the company has embarked on a path that fuses medical expertise with cutting-edge technology. The core of Shockwave's operation lies in its proprietary intravascular lithotripsy (IVL) technology, which employs sonic pressure waves to safely and effectively fracture problematic calcium deposits in the arteries. This approach not only enhances the safety profile compared to other invasive procedures but also improves the outcomes for patients enduring complex calcified lesions, a common hurdle in cardiovascular treatments. It's through the pioneering use of this technology that Shockwave Medical generates its revenue. The company's product portfolio, which includes devices like the Shockwave M5 and Shockwave C2 catheters, is designed to cater to a wide spectrum of calcified cardiovascular issues. By selling these devices directly to hospitals and healthcare providers across the globe and supporting them with robust clinical data showing improved patient outcomes, Shockwave has cemented its place in the medical device industry. Furthermore, its business model benefits from recurring revenues as healthcare providers continually purchase these specialized devices for ongoing procedures. This consistent demand underscores the company's balanced approach to innovation and profitability in a market primed for technological advancements.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Shockwave Medical Inc is 24.4%, which is below its 3-year median of 36.7%.
Over the last 3 years, Shockwave Medical Inc’s Net Margin has increased from -97.9% to 24.4%. During this period, it reached a low of -97.9% on Mar 3, 2021 and a high of 47.2% on Dec 31, 2022.